141 related articles for article (PubMed ID: 8984691)
1. [Empirical antimicrobial therapy in neutropenic patients].
Maschmeyer G
Ther Umsch; 1996 Nov; 53(11):854-62. PubMed ID: 8984691
[TBL] [Abstract][Full Text] [Related]
2. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
Jarque I; Sanz MA
Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
Link H; Böhme A; Cornely OA; Höffken K; Kellner O; Kern WV; Mahlberg R; Maschmeyer G; Nowrousian MR; Ostermann H; Ruhnke M; Sezer O; Schiel X; Wilhelm M; Auner HW; ;
Ann Hematol; 2003 Oct; 82 Suppl 2():S105-17. PubMed ID: 13680173
[TBL] [Abstract][Full Text] [Related]
4. [Management of febrile neutropenic patients].
Takata T; Tamura K
Gan To Kagaku Ryoho; 2006 Jan; 33(1):13-8. PubMed ID: 16410691
[TBL] [Abstract][Full Text] [Related]
5. The use of aminoglycosides in neutropenic patients.
Cometta A; Glauser MP
Schweiz Med Wochenschr Suppl; 1996; 76():21S-27S. PubMed ID: 8677415
[TBL] [Abstract][Full Text] [Related]
6. [Antimicrobial prophylaxis and therapy in neutropenia].
Link H
Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
[TBL] [Abstract][Full Text] [Related]
7. [Empirical antimicrobial therapy in neutropenic patients. Results of a multicenter study by the Infections in Hematology Study Group of the Paul Ehrlich Society].
Maschmeyer G; Link H; Hiddemann W; Meyer P; Helmerking M; Eisenmann E; Schmitt J; Adam D
Med Klin (Munich); 1994 Mar; 89(3):114-23. PubMed ID: 8196571
[TBL] [Abstract][Full Text] [Related]
8. Initial empirical antimicrobial therapy: duration and subsequent modifications.
Tamura K
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S59-64. PubMed ID: 15250024
[TBL] [Abstract][Full Text] [Related]
9. Management of fever in neutropenic patients with different risks of complications.
Klastersky J
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotic therapy in leukopenia].
Böhme A; Shah PM; Stille W; Hoelzer D
Praxis (Bern 1994); 1998 Sep; 87(36):1120-5. PubMed ID: 9782739
[TBL] [Abstract][Full Text] [Related]
11. [Antimicrobial therapy in neutropenia].
Maschmeyer G; Vogt K; Hahn H; Dörken B
Dtsch Med Wochenschr; 1997 Jul; 122(27):864-9. PubMed ID: 9280698
[No Abstract] [Full Text] [Related]
12. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
13. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
Offidani M; Corvatta L; Olivieri A; Rupoli S; Frayfer J; Mele A; Manso E; Montanari M; Centurioni R; Leoni P
Bone Marrow Transplant; 1999 Nov; 24(10):1079-87. PubMed ID: 10578158
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis and treatment of bacterial infections: do we need new strategies?
Micozzi A; Bucaneve G
Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
[TBL] [Abstract][Full Text] [Related]
15. Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey.
Yoshida M; Ohno R
Clin Infect Dis; 2004 Jul; 39 Suppl 1():S11-4. PubMed ID: 15250015
[TBL] [Abstract][Full Text] [Related]
16. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
Bal AM; Gould IM
Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A
Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179
[TBL] [Abstract][Full Text] [Related]
18. An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.
Glasmacher A; von Lilienfeld-Toal M; Schulte S; Hahn C; Schmidt-Wolf IG; Prentice A
Clin Microbiol Infect; 2005 Oct; 11 Suppl 5():17-23. PubMed ID: 16138815
[TBL] [Abstract][Full Text] [Related]
19. Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial.
Reich G; Cornely OA; Sandherr M; Kubin T; Krause S; Einsele H; Thiel E; Bellaire T; Dörken B; Maschmeyer G
Br J Haematol; 2005 Jul; 130(2):265-70. PubMed ID: 16029455
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of bacterial infections in neutropenic and immunocompromised patients].
Helbig W; Tauchnitz R
Z Gesamte Inn Med; 1992 Sep; 47(9):417-21. PubMed ID: 1441670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
